1 completed, 1 terminated, 1 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Toxic Optic Neuropathy: new trials by email Literature Review of Toxic Optic Neuropathy trials Research Report on Toxic Optic Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial. Recombinant human erythropoietin 4,000 UI and 2,000 UI, Methylprednisolone succinate 500 mg - Toxic Optic Neuropathy, Treatment | Phase 2 / Phase 3 | Unknown | Asociación para Evitar la Ceguera en México | 18 | 2022-04-05 | 2023-02-28 |
| Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy. Neuroimaging, VEP - visual evoked potential, Ophthalmology examination. - Ischemic Optic Neuropathy, Optic Neuritis | Not applicable | Terminated | Medical University of Bialystok | 7 | 2020-01-01 | 2026-10-23 |
| Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation Wharton jelly derived mesenchymal stem cell, Repetitive electromagnetic stimulation - Methanol Poisoning, Toxic Optic Neuropathy | Phase 3 | Completed | Ankara Universitesi Teknokent | 18 | 2019-04-01 | 2021-05-10 |
Optic Nerve Diseases (1) · Optic Nerve Injuries (1) · Optic Neuritis (1) · Optic Neuropathy, Ischemic (1)
Chemically-Induced Disorders (3) · Cranial Nerve Diseases (3) · Cranial Nerve Injuries (3) · Craniocerebral Trauma (3) · Drug-Related Side Effects and Adverse Reactions (3) · Eye Diseases (3) · Nervous System Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Radiation Injuries (3) · Trauma, Nervous System (3) · Wounds and Injuries (3) · Optic Nerve Diseases (2) · Optic Nerve Injuries (2) · Cardiovascular Diseases (1)
Control Groups (1) · Methylprednisolone Hemisuccinate (1) · Neuroimaging (1)
Ankara Universitesi Teknokent (1) · Asociación para Evitar la Ceguera en México (1) · Medical University of Bialystok (1)
Mexico (1) · Poland (1) · Turkey (Türkiye) (1)